An earlier study identified increased susceptibility to complement attack due to down-regulation of DAF1/CD55 and DAF2/CD55b only in dysferlin-deficient muscles, demonstrated by mRNA and protein analyses in dysferlin-deficient mouse models and patients with dysferlinopathy [52]. Here, CD55 is linked to neuromuscular disease caused by qualitative or quantitative defects of dysferlin.